Getting Contracts Right for Active MedTech Projects

In this presentation by Lis Boyce from Dentons, we take a closer look at the world of contracts and how to set up your MedTech business with the end in mind.
Active MedTech projects can involve many stakeholders including investors, suppliers and multiple owners. It's important that the agreements with these stakeholders cover all the possible scenarios that can arise during complex medical device development.
The presentation beings with understanding why contracts should be in place at all, even when engaging with trusted partners. Lis examines the kinds of things that could go wrong and how to protect against the issues that might arise.
We then look at the range of agreements that are required starting with non-disclosure agreements and supplier agreements, through to those required with investors and shareholders. through to shareholder agreements.
Central to the role of all of these agreements is intellectual property which can be quite complex, especially where multiple parties are contributing IP including suppliers and R&D organisations such as universities.
Lis Boyce is a partner at Dentons, and co-chairs Dentons' life sciences group in Australia and is the Australian lead for Dentons' global Venture Technology Group. Lis is experienced in helping start-ups through to IPO and regularly works with research institutes. She is the chair of AusBiotech’s AusMedtech special interest group in NSW, and is Deputy Chair of AusMedtech’s National Advisory Group.